首页> 外文期刊>Biochemical and Biophysical Research Communications >Comparative study of the chondrogenic potential of human bone marrow stromal cells, neonatal chondrocytes and adult chondrocytes.
【24h】

Comparative study of the chondrogenic potential of human bone marrow stromal cells, neonatal chondrocytes and adult chondrocytes.

机译:人骨髓基质细胞,新生儿软骨细胞和成年软骨细胞软骨形成潜力的比较研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Cartilage tissue engineering is still a major clinical challenge with optimisation of a suitable source of cells for cartilage repair/regeneration not yet fully addressed. The aims of this study were to compare and contrast the differences in chondrogenic behaviour between human bone marrow stromal cells (HBMSCs), human neonatal and adult chondrocytes to further our understanding of chondroinduction relative to cell maturity and to identify factors that promote chondrogenesis and maintain functional homoeostasis. Cells were cultured in monolayer in either chondrogenic or basal medium, recapitulating procedures used in existing clinical procedures for cell-based therapies. Cell doubling time, morphology and alkaline phosphatase specific activity (ALPSA) were determined at different time points. Expression of chondrogenic markers (SOX9, ACAN and COL2A1) was compared via real time polymerase chain reaction. Amongst the three cell types studied, HBMSCs had the highest ALPSA in basal culture and lowest ALPSA in chondrogenic media. Neonatal chondrocytes were the most proliferative and adult chondrocytes had the lowest ALPSA in basal media. Gene expression analysis revealed a difference in the temporal expression of chondrogenic markers which were up regulated in chondrogenic medium compared to levels in basal medium. Of the three cell types studied, adult chondrocytes offer a more promising cell source for cartilage tissue engineering. This comparative study revealed differences between the microenvironment of all three cell types and provides useful information to inform cell-based therapies for cartilage regeneration.
机译:软骨组织工程学仍然是主要的临床挑战,因为尚未完全解决用于软骨修复/再生的合适细胞来源的优化。这项研究的目的是比较和对比人类骨髓基质细胞(HBMSC),人类新生儿和成年软骨细胞在软骨形成行为方面的差异,以进一步了解软骨诱导与细胞成熟的关系,并确定促进软骨形成和维持功能的因素同稳态。在软骨形成或基础培养基中单层培养细胞,概括了现有的基于细胞疗法的临床程序中使用的程序。在不同时间点确定细胞倍增时间,形态和碱性磷酸酶比活性(ALPSA)。通过实时聚合酶链反应比较软骨形成标记(SOX9,ACAN和COL2A1)的表达。在所研究的三种细胞类型中,HBMSC在基础培养中的ALPSA最高,在软骨形成培养基中的ALPSA最低。新生软骨细胞增殖最多,而成年软骨细胞在基础培养基中的ALPSA最低。基因表达分析显示,与基础培养基中的水平相比,在软骨原性培养基中上调的软骨原性标志物的时间表达有所不同。在研究的三种细胞类型中,成年软骨细胞为软骨组织工程提供了更有希望的细胞来源。这项比较研究揭示了所有三种细胞类型的微环境之间的差异,并为指导基于细胞的软骨再生疗法提供了有用的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号